In this study, we have taken the unique approach to assess the effects of surgery on depression ratings for a set of patients with growth hormone secreting tumors and compared the effects to a control group of patients with surgery for non-functioning pituitary tumors. The gene discussed is GH1; the disease is depressive symptom measurement.